Raziel Green, 52, an active runner and mother of two, was diagnosed with a rare form of ALS in 2017. Since starting a ...
New Medication For Als Eligible For Fast-track Fda Approval "A couple months later, I started to struggle going up the stairs at my house," she recalled. Several months later, when Green started ...
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN)* has announced significant progress toward the early commercialization of PrimeC in Canada. According to a Form 6-K filed with the SEC this morning, Health ...
ALS Canada has named 39 Canadians to receive the King Charles III Coronation Medal for their efforts into research and advocacy for ALS.
Columnist Dagmar Munn decides to talk about her own experience and stay in her lane of wellness, motivation, and stress in ...
With ongoing breakthroughs in gene and RNA therapies, coupled with regulatory encouragement and AI-based innovation, the market for treating rare neurological diseases is on the cusp of a ...
With the initial phase of Empire AI up and running, select UB researchers are employing the center’s powerful computers to ...
The primary value of placebo controls in clinical trials is the minimization of bias.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results